| ALESSE 21 (20 MCG) | 02236974 | Marketed | Pfizer Canada Ulc | Apr 2012 |
| ALESSE 28 (20 MCG) | 02236975 | Marketed | Pfizer Canada Ulc | Mar 2012 |
| ALYSENA 21 (20 MCG) | 02387875 | Marketed | Apotex Inc. | Nov 2012 |
| ALYSENA 28 (20 MCG) | 02387883 | Marketed | Apotex Inc. | Nov 2012 |
| AMB-CYPROTERONE ACETATE / ETHINYL ESTRADIOL (0.035 MG) | 02564424 | Marketed | Ambicare Pharmaceuticals Inc. | Mar 2026 |
| APRI 21 (0.03 MG) | 02317192 | Marketed | Teva Canada Limited | May 2015 |
| APRI 28 (0.03 MG) | 02317206 | Marketed | Teva Canada Limited | May 2015 |
| AUDRINA 21 (20 MCG) | 02532174 | Marketed | JAMP Pharma Corporation | Jun 2023 |
| AUDRINA 28 (20 MCG) | 02532182 | Marketed | JAMP Pharma Corporation | Jun 2023 |
| AVIANE 21 (20 MCG) | 02298538 | Marketed | Teva Canada Limited | May 2015 |
| AVIANE 28 (20 MCG) | 02298546 | Marketed | Teva Canada Limited | May 2015 |
| BREVICON 0.5/35 TABLETS (21-DAY PACK) (0.035 MG) | 02187086 | Marketed | Pfizer Canada Ulc | Feb 2009 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) (.035 MG) | 02187094 | Marketed | Pfizer Canada Ulc | Apr 2006 |
| BREVICON 1/35 TABLETS (21-DAY PACK) (0.035 MG) | 02189054 | Marketed | Pfizer Canada Ulc | Feb 2009 |
| BREVICON 1/35 TABLETS (28-DAY PACK) (0.035 MG) | 02189062 | Marketed | Pfizer Canada Ulc | Feb 2009 |
| CLÉO -35 (0.035 MG) | 02436736 | Marketed | Altius Healthcare Inc | May 2018 |
| CYESTRA-35 (0.035 MG) | 02290308 | Marketed | Knight Therapeutics Inc. | Feb 2026 |
| DIANE-35 (35 MCG) | 02233542 | Marketed | Bayer Inc. | Dec 2007 |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP (0.02 MG) | 02462060 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Sep 2021 |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 (0.03 MG) | 02421437 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Oct 2021 |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 (0.03 MG) | 02421445 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Oct 2021 |
| ELFY (10 MCG) | 02553481 | Marketed | Apotex Inc. | Apr 2026 |
| EVRA (35 MCG) | 02248297 | Marketed | Searchlight Pharma Inc. | Oct 2022 |
| FREYA 21 (0.03 MG) | 02396491 | Marketed | Senador Laboratories Private Limited | Sep 2026 |
| FREYA 28 (0.03 MG) | 02396610 | Marketed | Senador Laboratories Private Limited | Sep 2026 |
| HALOETTE (2.7 MG) | 02520028 | Marketed | Searchlight Pharma Inc. | Sep 2021 |
| INDAYO (0.03 MG) | 02398869 | Marketed | Senador Laboratories Private Limited | Jul 2026 |
| LAYLAA 21 (20 MCG) | 02424282 | Marketed | Lupin Pharma Canada Limited | Nov 2023 |
| LAYLAA 28 (20 MCG) | 02424290 | Marketed | Lupin Pharma Canada Limited | Nov 2023 |
| LINESSA 21 (0.025 MG) | 02272903 | Marketed | Aspen Pharmacare Canada Inc. | Feb 2019 |
| LINESSA 28 (0.025 MG) | 02257238 | Marketed | Aspen Pharmacare Canada Inc. | May 2019 |
| LOLO (10 MCG) | 02417456 | Marketed | AbbVie Corporation | May 2024 |
| MARVELON 21 (0.03 MG) | 02042487 | Marketed | Organon Canada Inc. | May 2022 |
| MARVELON 28 (0.03 MG) | 02042479 | Marketed | Organon Canada Inc. | Jun 2022 |
| MILEY 21 (0.03 MG) | 02556553 | Marketed | Ambicare Pharmaceuticals Inc. | Aug 2025 |
| MILEY 28 (0.03 MG) | 02556561 | Marketed | Ambicare Pharmaceuticals Inc. | Aug 2025 |
| MIN-OVRAL 21 (30 MCG) | 02042320 | Marketed | Pfizer Canada Ulc | Dec 2011 |
| MIN-OVRAL 28 (30 MCG) | 02042339 | Marketed | Pfizer Canada Ulc | Nov 2011 |
| MIRVALA 21 (0.0300 MG) | 02410249 | Marketed | Apotex Inc. | Jan 2014 |
| MIRVALA 28 (0.0300 MG) | 02410257 | Marketed | Apotex Inc. | Jan 2014 |
| MYA (0.02 MG) | 02415380 | Marketed | Apotex Inc. | Sep 2020 |
| NUVARING (2.6 MG) | 02253186 | Marketed | Organon Canada Inc. | Feb 2022 |
| OVIMA 21 (30 MCG) | 02387085 | Marketed | Apotex Inc. | Aug 2013 |
| OVIMA 28 (30 MCG) | 02387093 | Marketed | Apotex Inc. | Aug 2013 |
| PORTIA 21 (0.03 MG) | 02295946 | Marketed | Teva Canada Limited | May 2015 |
| PORTIA 28 (0.03 MG) | 02295954 | Marketed | Teva Canada Limited | May 2015 |
| RINGZA (17.4 MG) | 02554070 | Marketed | Duchesnay Inc. | Mar 2026 |
| SEASONALE (0.03 MG) | 02296659 | Marketed | Teva Canada Limited | Sep 2022 |
| SEASONIQUE (0.01 MG) | 02346176 | Marketed | Teva Canada Limited | Jun 2022 |
| SELECT 1/35 (21-DAY) (0.035 MG) | 02197502 | Marketed | Pfizer Canada Ulc | Feb 2006 |
| SELECT 1/35 (28-DAY) (0.035 MG) | 02199297 | Marketed | Pfizer Canada Ulc | Jan 2005 |
| SYNPHASIC 21 TABLETS (0.035 MG) | 02187108 | Marketed | Pfizer Canada Ulc | Feb 2009 |
| SYNPHASIC 28 TABLETS (0.035 MG) | 02187116 | Marketed | Pfizer Canada Ulc | Jul 2006 |
| TARO-CYPROTERONE/ETHINYL ESTRADIOL (0.035 MG) | 02425017 | Marketed | Sun Pharma Canada Inc. | Aug 2020 |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL (0.035 MG) | 02309556 | Marketed | Teva Canada Limited | Mar 2018 |
| TRI-CIRA 21 (0.035 MG) | 02508087 | Marketed | Apotex Inc. | Mar 2021 |
| TRI-CIRA 28 (0.035 MG) | 02508095 | Marketed | Apotex Inc. | Mar 2021 |
| TRI-CIRA LO 21 (0.025 MG) | 02401967 | Marketed | Apotex Inc. | Mar 2021 |
| TRI-CIRA LO 28 (0.025 MG) | 02401975 | Marketed | Apotex Inc. | Mar 2021 |
| TRI-JORDYNA 21 (0.035 MG) | 02486296 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Jul 2020 |
| TRI-JORDYNA 28 (0.035 MG) | 02486318 | Marketed | Glenmark Pharmaceuticals Canada Inc. | Mar 2020 |
| TRIQUILAR 21 (30 MCG) | 00707600 | Marketed | Bayer Inc. | Jul 2008 |
| TRIQUILAR 28 (30 MCG) | 00707503 | Marketed | Bayer Inc. | May 2008 |
| YASMIN 21 (0.03 MG) | 02261723 | Marketed | Bayer Inc. | Dec 2007 |
| YASMIN 28 (0.03 MG) | 02261731 | Marketed | Bayer Inc. | Nov 2007 |
| YAZ (0.02 MG) | 02321157 | Marketed | Bayer Inc. | Jan 2009 |
| YAZ PLUS (0.02 MG) | 02387433 | Marketed | Bayer Inc. | Mar 2013 |
| ZAMINE 21 (0.03 MG) | 02410788 | Marketed | Apotex Inc. | Sep 2020 |
| ZAMINE 28 (0.03 MG) | 02410796 | Marketed | Apotex Inc. | Sep 2020 |
| GERI-TONE (0.005 MG) | 02338386 | Approved | Sante Animale Anivet Inc | Nov 2009 |
| NIKKI (0.02 MG) | 02416492 | Approved | Lupin Limited | Jun 2014 |
| QISMETTE 21 (0.030 MG) | 02416506 | Approved | Lupin Limited | Nov 2013 |
| QISMETTE 28 (0.030 MG) | 02416514 | Approved | Lupin Limited | Nov 2013 |
| QUATERNA (0.01 MG) | 02426927 | Approved | Mylan Pharmaceuticals Ulc | Jul 2023 |
| VLOOP (3.474 MG) | 02560887 | Approved | JAMP Pharma Corporation | Sep 2025 |
| BREVICON 0.5/35 21 TAB (.035 MG) | 00373265 | Cancelled Post Market | Syntex Inc. | Sep 1996 |
| BREVICON 0.5/35 28 TAB (.035 MG) | 00373273 | Cancelled Post Market | Syntex Inc. | Sep 1996 |
| BREVICON 1/35 21 TAB (.035 MG) | 00531006 | Cancelled Post Market | Syntex Inc. | Sep 1996 |
| BREVICON 1/35 28 TAB (.035 MG) | 00531014 | Cancelled Post Market | Syntex Inc. | Sep 1996 |
| CENTRISA 21 (0.035 MG) | 02411199 | Cancelled Pre Market | Patriot A Division Of Janssen Inc | Aug 2017 |
| CENTRISA 28 (0.035 MG) | 02411202 | Cancelled Pre Market | Patriot A Division Of Janssen Inc | Aug 2017 |
| CENTRISA LO 21 (0.025 MG) | 02411431 | Cancelled Pre Market | Patriot A Division Of Janssen Inc | Aug 2017 |
| CENTRISA LO 28 (0.025 MG) | 02411458 | Cancelled Pre Market | Patriot A Division Of Janssen Inc | Aug 2017 |
| CYCLEN TABLETS (21 DAY) (0.035 MG) | 01968440 | Cancelled Post Market | Janssen Inc. | Aug 2020 |
| CYCLEN TABLETS (28 DAY) (0.035 MG) | 01992872 | Cancelled Post Market | Janssen Inc. | Jun 2020 |
| DEMULEN 30 (21 DAY PACK) (30 MCG) | 00469327 | Cancelled Post Market | Pfizer Canada Ulc | Jul 2019 |
| DEMULEN 30 (28 DAY PACK) (30 MCG) | 00471526 | Cancelled Post Market | Pfizer Canada Ulc | Jul 2019 |
| DEMULEN 50 (21 DAY PACK) (50 MCG) | 00028630 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2005 |
| DEMULEN 50 (28 DAY PACK) (50 MCG) | 00343536 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2005 |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS (0.02 MG) | 02425726 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2025 |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21 (0.03 MG) | 02424452 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2025 |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 (0.03 MG) | 02424460 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2025 |
| ESME 21 (20 MCG) | 02388138 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| ESME 28 (20 MCG) | 02388146 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| ESTINYL TAB 0.05MG (.05 MG) | 00028223 | Cancelled Post Market | Schering-Plough Canada Inc. | Jul 2000 |
| ESTINYL TAB 0.5MG (.5 MG) | 00028231 | Cancelled Post Market | Schering-Plough Canada Inc. | Jul 2000 |
| ESTINYL TABLETS 0.02 MG. (.02 MG) | 00028215 | Cancelled Post Market | Schering-Plough Canada Inc. | Nov 1998 |
| EVRA -(6/0.75) (0.75 MG) | 02246340 | Cancelled Post Market | Janssen Inc. | Feb 2006 |
| FEMHRT (5 MCG) | 02242531 | Cancelled Post Market | Warner Chilcott Canada Co | Aug 2016 |
| GENERESS (0.025 MG) | 02435659 | Cancelled Pre Market | Allergan Inc | Jul 2021 |
| GERI BONS TAB (5 MCG) | 00213039 | Cancelled Post Market | Ormond Veterinary Supply Ltd. | Jul 2000 |
| GERI-TABS (5 MCG) | 00436674 | Cancelled Post Market | Vetoquinol N A Inc | Mar 2010 |
| LO-FEMENAL 21 TABLETS (30 MCG) | 02215640 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2014 |
| LOESTRIN 1.5/30 (30 MCG) | 00297143 | Cancelled Post Market | Allergan Inc | Apr 2022 |
| LOESTRIN 1.5/30 (30 MCG) | 00353027 | Cancelled Post Market | Allergan Inc | Jan 2022 |
| LUTERA 21 (20.0 MCG) | 02401185 | Cancelled Post Market | Cobalt Pharmaceuticals Incorporated | Jun 2018 |
| LUTERA 28 (20.0 MCG) | 02401207 | Cancelled Post Market | Cobalt Pharmaceuticals Incorporated | Jun 2018 |
| MARFEM 21 (0.03 MG) | 02328828 | Cancelled Pre Market | Novopharm Limited | Oct 2015 |
| MARFEM 28 (0.03 MG) | 02328836 | Cancelled Pre Market | Novopharm Limited | Oct 2015 |
| MIN-OVRAL 21 TAB (0.03 MG) | 00782432 | Cancelled Post Market | Wyeth Ltd. | Sep 1996 |
| MIN-OVRAL 28 TAB (.03 MG) | 00782440 | Cancelled Post Market | Wyeth Ltd. | Sep 1996 |
| MINESTRIN 1/20 (20 MCG) | 00343838 | Cancelled Post Market | Allergan Inc | Apr 2022 |
| MINESTRIN 1/20 (20 MCG) | 00315966 | Cancelled Post Market | Allergan Inc | Apr 2022 |
| MYLAN-CYPROTERONE / ETHINYLESTRADIOL (0.035 MG) | 02491257 | Cancelled Pre Market | Mylan Pharmaceuticals Ulc | Feb 2022 |
| NEO MENS TAB (.05 MG) | 00018953 | Cancelled Post Market | Neolab Inc | Aug 1997 |
| ORTHO 0.5/35 TABLETS (21 DAY) (.035 MG) | 00317047 | Cancelled Post Market | Janssen Inc. | Sep 2017 |
| ORTHO 0.5/35 TABLETS (28 DAY) (0.035 MG) | 00340731 | Cancelled Post Market | Janssen Inc. | Sep 2017 |
| ORTHO 1/35 TABLETS (21 DAY) (.035 MG) | 00372846 | Cancelled Post Market | Janssen Inc. | Sep 2017 |
| ORTHO 1/35 TABLETS (28 DAY) (.035 MG) | 00372838 | Cancelled Post Market | Janssen Inc. | Sep 2017 |
| ORTHO 10/11 TABLETS (21 DAY) (.035 MG) | 00538590 | Cancelled Post Market | Janssen Inc. | Jul 2002 |
| ORTHO 10/11 TABLETS (28 DAY) (.035 MG) | 00538582 | Cancelled Post Market | Janssen Inc. | Jul 2002 |
| ORTHO 7/7/7 TABLETS (21 DAY) (0.035 MG) | 00602957 | Cancelled Post Market | Janssen Inc. | Sep 2017 |
| ORTHO 7/7/7 TABLETS (28 DAY) (0.035 MG) | 00602965 | Cancelled Post Market | Janssen Inc. | Sep 2017 |
| ORTHO-CEPT TABLETS (21 DAY) (0.03 MG) | 02042541 | Cancelled Post Market | Janssen Inc. | Aug 2007 |
| ORTHO-CEPT TABLETS (28 DAY) (0.03 MG) | 02042533 | Cancelled Post Market | Janssen Inc. | Apr 2015 |
| OVRAL 21 (50 MCG) | 02043033 | Cancelled Post Market | Pfizer Canada Ulc | Sep 2010 |
| OVRAL 21 TAB (.05 MG) | 00034207 | Cancelled Post Market | Wyeth Ltd. | Aug 1997 |
| OVRAL 28 TABLETS (50 MCG) | 02043041 | Cancelled Post Market | Wyeth Canada | Aug 2006 |
| OVRAL 28TAB (.05 MG) | 00340766 | Cancelled Post Market | Wyeth Ltd. | Sep 1996 |
| PREVEN EMERGENCY CONTRACEPTIVE (0.05 MG) | 02239806 | Cancelled (Unreturned Annual) | Gynetics Ltd | Sep 2017 |
| PREVEN TABLETS (0.05 MG) | 02240544 | Cancelled Post Market | Shire Pharma Canada Ulc | Aug 2001 |
| PREVIFEM (21DAY) (0.035 MG) | 02320061 | Cancelled Pre Market | Novopharm Limited | Jul 2018 |
| PREVIFEM (28DAY) (0.035 MG) | 02320088 | Cancelled Pre Market | Novopharm Limited | Jul 2018 |
| RECLIPSEN 21 (0.03 MG) | 02420813 | Cancelled Post Market | Actavis Pharma Company | Apr 2018 |
| RECLIPSEN 28 (0.03 MG) | 02417464 | Cancelled Post Market | Actavis Pharma Company | Apr 2018 |
| SARENSIS 21 (0.035 MG) | 02411466 | Cancelled Pre Market | Patriot A Division Of Janssen Inc | Aug 2017 |
| SARENSIS 28 (0.035 MG) | 02411474 | Cancelled Pre Market | Patriot A Division Of Janssen Inc | Aug 2017 |
| SYNPHASIC 21 TABLETS (.035 MG) | 00620947 | Cancelled Post Market | Syntex Inc. | Sep 1996 |
| SYNPHASIC-28 TABLETS (.035 MG) | 00695734 | Cancelled Post Market | Syntex Inc. | Sep 1996 |
| TRI-CYCLEN LO (21 DAY) (0.025 MG) | 02258560 | Cancelled Post Market | Janssen Inc. | Aug 2020 |
| TRI-CYCLEN LO (28 DAY) (0.025 MG) | 02258587 | Cancelled Post Market | Janssen Inc. | Sep 2020 |
| TRI-CYCLEN TABLETS - 21-DAY (0.035 MG) | 02028700 | Cancelled Post Market | Janssen Inc. | Jun 2020 |
| TRI-CYCLEN TABLETS - 28-DAY (0.035 MG) | 02029421 | Cancelled Post Market | Janssen Inc. | Mar 2020 |
| TRI-LENA 21 (0.035 MG) | 02443597 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| TRI-LENA 28 (0.035 MG) | 02443600 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| TRI-LENA LO 21 (0.025 MG) | 02443457 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| TRI-LENA LO 28 (0.025 MG) | 02443465 | Cancelled Pre Market | Actavis Pharma Company | Sep 2017 |
| TRI-PREVIFEM (21 DAY) (0.035 MG) | 02320096 | Cancelled Pre Market | Novopharm Limited | Jul 2018 |
| TRI-PREVIFEM (28 DAY) (0.035 MG) | 02320118 | Cancelled Pre Market | Novopharm Limited | Jul 2018 |
| TRIPHASIL 21 (30 MCG) | 02043726 | Cancelled Post Market | Wyeth Canada | Oct 2007 |
| TRIPHASIL 21 TAB (30 MCG) | 00782416 | Cancelled Post Market | Wyeth Ltd. | Sep 1996 |
| TRIPHASIL 28 (30 MCG) | 02043734 | Cancelled Post Market | Wyeth Canada | Oct 2007 |
| TRIPHASIL 28 TAB (30 MCG) | 00782424 | Cancelled Post Market | Wyeth Ltd. | Sep 1996 |
| VESTURA (0.02 MG) | 02404575 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Jan 2020 |
| YASMIN PLUS (0.03 MG) | 02442744 | Cancelled Pre Market | Bayer Inc. | Nov 2024 |
| ZARAH 21 (0.03 MG) | 02385058 | Cancelled Post Market | Cobalt Pharmaceuticals Incorporated | Nov 2018 |
| ZARAH 28 (0.03 MG) | 02385066 | Cancelled Post Market | Cobalt Pharmaceuticals Incorporated | Nov 2018 |